Document Detail


Pharmacological treatment of elderly patients with acute coronary syndromes without persistent ST segment elevation.
MedLine Citation:
PMID:  12381234     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Evidence-based management of acute coronary syndromes (ACS) without persistent ST segment elevation involves a rational, stepwise approach to the selection of therapies with potential benefit for elderly patients. Specifically, in elderly patients with ACS without persistent ST segment elevation, therapy should be administered based on the likelihood of unstable angina or non-ST elevation myocardial infarction being present and the risks and benefits of each individual therapy. All elderly patients with suspected ACS should receive anti-ischaemic therapy consisting of beta-blockers and nitrates, and antiplatelet therapy with aspirin unless clear contraindications exist. For patients with a moderate likelihood of ACS being present, defined as prior coronary disease or recurrent pain despite the use of anti-ischaemic therapies, unfractionated heparin or enoxaparin should be added to aspirin for more intense anticoagulation. In patients with high-risk clinical features, defined as ischaemic electrocardiographic changes and positive cardiac markers such as troponins, therapy with clopidogrel or glycoprotein IIb/IIIa inhibitors should be considered in addition to aspirin and heparin. Furthermore, high-risk patients should be managed with an early invasive strategy that includes prompt cardiac catheterisation within 24 to 48 hours and appropriate use of revascularisation as determined by the findings of the catheterisation. An evidence-based approach to the treatment of elderly patients with ACS without persistent ST segment elevation will help to improve the use of beneficial therapies and interventions that are recommended by current practice guidelines.
Authors:
Manesh R Patel; Matthew T Roe
Related Documents :
10889124 - Oral glycoprotein iib/iiia inhibition with orbofiban in patients with unstable coronary...
10715254 - Aspirin use is low among united states outpatients with coronary artery disease.
11419424 - Comparison of early invasive and conservative strategies in patients with unstable coro...
12143264 - Clopidogrel and acute coronary syndrome.
7064814 - Improvement of left ventricular function after percutaneous transluminal coronary angio...
24513464 - Clinical significance of late gadolinium enhancement in patients <20 years of age with ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Drugs & aging     Volume:  19     ISSN:  1170-229X     ISO Abbreviation:  Drugs Aging     Publication Date:  2002  
Date Detail:
Created Date:  2002-10-16     Completed Date:  2002-11-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9102074     Medline TA:  Drugs Aging     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  633-46     Citation Subset:  IM    
Affiliation:
Duke University Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Administration, Oral
Adrenergic beta-Antagonists / therapeutic use
Aged
Clinical Trials as Topic
Coronary Disease / drug therapy*
Drug Therapy, Combination
Fibrinolytic Agents / therapeutic use
Humans
Injections, Intravenous
Nitrates / therapeutic use
Platelet Aggregation Inhibitors / therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
Syndrome
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Fibrinolytic Agents; 0/Nitrates; 0/Platelet Aggregation Inhibitors; 0/Platelet Glycoprotein GPIIb-IIIa Complex

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The drive for quality care in US nursing homes in the era of the prospective payment system.
Next Document:  HIV disease and advanced age: an increasing therapeutic challenge.